SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (5360)8/26/1998 5:33:00 PM
From: George Acton  Read Replies (1) of 7041
 
| I wonder when, or should I say, at what time, ZONA will drop
| through 17? Any thoughts on how long it can hang there?

I'm an idiot concerning any kind of market timing. I think that
in the real world, the FDA could send them a letter saying that
Vasomax doesn't qualify for serious review, and that could come
in a few weeks to a few months. Obviously, the effect on the
share price would not be favorable. If the FDA sends it to
a review panel it could take months for a definitive answer.
In that case, the company has enough cash to operate for a
long time and hopes for approval could keep the price up.
Other considerations such as the total size of the market,
patient satisfaction with Viagra and the success or failure
of other ED drugs would affect the prospects for Vasomax and
the price.

--George Acton
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News